News

Filter

Current filters:

None

1 to 9 of 97895 results

CASI Pharmaceuticals appoints Rong Chen as chief medical officer

CASI Pharmaceuticals appoints Rong Chen as chief medical officer

04-03-2015

Oncology biopharma company CASI Pharmaceuticals has appointed Rong Chen as chief medical officer.

BoardroomCASICASI PharmaceuticalsGlaxoSmithKlinePharmaceutical

Patent reform bill to protect innovation, confront abuse introduced in USA

Patent reform bill to protect innovation, confront abuse introduced in USA

04-03-2015

US Senators Chris Coons (Democrat, Delaware) and Dick Durbin (Democrat, Illinois), members of the Senate…

LegalPatentsPharmaceuticalPoliticsUSA

Takeda promotes Christophe Weber to chief executive

Takeda promotes Christophe Weber to chief executive

04-03-2015

Japan’s largest drugmaker Takeda Pharmaceutical has promoted Christophe Weber from representative director,…

BoardroomJapanPharmaceuticalTakeda PharmaTakeda Pharmaceutical

Orexigen shares jump on Contrave trial interim data but FDA orders more cardio studies

Orexigen shares jump on Contrave trial interim data but FDA orders more cardio studies

04-03-2015

The US Food and Drug Administration has said it is “disappointed” by Orexigen Therapeutics’ decision…

ContraveMetabolicsNeurologicalOrexigen TherapeuticsPharmaceuticalRegulationUSA

FDA formally accepts Actelion's NDA for Uptravi

FDA formally accepts Actelion's NDA for Uptravi

04-03-2015

Switzerland-based Actelion, Europe’s largest biotech company, says that the US Food and Drug Administration…

ActelionBiotechnologyRegulationRespiratory and PulmonaryselexipagUptraviUSA

Bavarian Nordic set to earn $975 million in Prostvac deal

Bavarian Nordic set to earn $975 million in Prostvac deal

04-03-2015

Danish biotech firm Bavarian Nordic has granted US pharma major Bristol-Myers Squibb an exclusive option…

Bavarian NordicBiotechnologyBristol-Myers SquibbLicensingOncologyProstvacVaccinesYervoy

First launch for Eisai’s Lenvima, in the USA

First launch for Eisai’s Lenvima, in the USA

03-03-2015

The US subsidiary of Japanese pharma major Eisai has now launched its in-house developed novel anticancer…

EisailenvatinibLenvimaMarkets & MarketingOncologyPharmaceuticalRare diseases

1 to 9 of 97895 results

COMPANY SPOTLIGHT

Menarini

Back to top